Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Autor: Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM, Løken-Amsrud, Kristin I, Holmøy, Trygve, Bakke, Søren J, Beiske, Antonie Giaever, Bjerve, Kristian S

Publikováno v: Neurology; 7/17/2012, Vol. 79 Issue 3, p267-273, 7p

No association of tobacco use and disease activity in multiple sclerosis.

Autor: Kvistad S; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Myhr KM; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Holmøy T; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Benth JŠ; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Løken-Amsrud KI; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Wergeland S; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Beiske AG; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Bjerve KS; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Hovdal H; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Lilleås F; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Midgard R; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Pedersen T; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Bakke SJ; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway., Torkildsen Ø; Department of Immunology and Transfusion Medicine (S.K.), Norwegian Multiple Sclerosis Competence Centre, Department of Neurology (S.K., S.W., Ø.T.), and Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology (K.-M.M., S.W., Ø.T.), Haukeland University Hospital, Bergen; KG Jebsen MS Research Centre (S.K., K.-M.M., Ø.T.), Department of Clinical Medicine, University of Bergen; Department of Neurology (T.H.), and HØKH, Research Centre (J.Š.B.), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (T.H., J.Š.B.), University of Oslo; Department of Neurology (K.I.L.-A.), Innlandet Hospital Trust, Lillehammer; Multiple Sclerosis Centre Hakadal (A.G.B.); Clinic of Laboratory Medicine (K.S.B.) and Department of Neurology (H.H.), St. Olavs Hospital, Trondheim University Hospital; Department of Laboratory Medicine (K.S.B.), Children's and Women's Health, Norwegian University of Science and Technology, Trondheim; Curato Oslo (F.L.); Department of Neurology (R.M.), Molde Hospital; Unit for Applied Clinical Research (R.M.), Norwegian University of Science and Technology, Trondheim; Unilabs Drammen (T.P.), Drammen; and Department of Neuroradiology (S.J.B.), Oslo University Hospital Rikshospitalet, Norway.

Publikováno v: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2016 Jul 14; Vol. 3 (4), pp. e260. Date of Electronic Publication: 2016 Jul 14 (Print Publication: 2016).

Impact of the environment on multiple sclerosis.

Autor: Løken-Amsrud KI; Nevrologisk avdeling Sykehuset Innlandet Lillehammer., Lossius A; Avdeling for immunologi og transfusjonsmedisin Oslo universitetssykehus, Rikshospitalet., Torkildsen Ø; Nevrologisk avdeling Haukeland universitetssykehus og KG Jebsen senter for MS-forskning Klinisk institutt 1 Universitetet i Bergen., Holmøy T; Nevroklinikken Akershus universitetssykehus og Institutt for klinisk medisin Universitetet i Oslo.

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2015 May 19; Vol. 135 (9), pp. 856-60. Date of Electronic Publication: 2015 May 19 (Print Publication: 2015).

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Autor: Kvistad S; Norwegian MS Competence Centre, Haukeland University Hospital, Jonas Lies vei 65, 5053 Bergen, Norway silje.agnethe.stokke@helse-bergen.no., Myhr KM; Norwegian MS Competence Centre, Haukeland University Hospital, Norway/KG Jebsen Center for MS Research, University of Bergen, Norway/Norwegian MS Registry and Biobank, Haukeland University Hospital, Norway., Holmøy T; Institute of Clinical Medicine, University of Oslo, Norway/Akershus University Hospital, Norway., Bakke S; Oslo University Hospital, Norway., Beiske AG; MS Centre Hakadal, Norway., Bjerve KS; St. Olav's Hospital, Trondheim University Hospital, Norway/Children's and Women's Health, Norwegian University of Science and Technology, Norway., Hovdal H; St Olav's Hospital, Trondheim University Hospital, Norway., Løken-Amsrud KI; Institute of Clinical Medicine, University of Oslo, Norway/Innlandet Hospital Trust, Norway., Lilleås F; Curato Oslo, Norway., Midgard R; Molde Hospital, Norway/Unit for Applied Clinical Research, Norwegian University of Science and Technology, Norway., Njølstad G; Haukeland University Hospital, Norway., Pedersen T; Unilabs Drammen, Norway., Benth JŠ; Institute of Clinical Medicine, University of Oslo, Norway/Helse Sør-Øst Health Services Research Centre, Akershus University Hospital, Norway., Wergeland S; Norwegian MS Competence Centre, Haukeland University Hospital, Norway/KG Jebsen Center for MS Research, University of Bergen, Norway., Torkildsen O; Norwegian MS Competence Centre, Haukeland University Hospital, Norway/KG Jebsen Center for MS Research, University of Bergen, Norway.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2014 Dec; Vol. 20 (14), pp. 1833-40. Date of Electronic Publication: 2014 May 19.

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.

Autor: Torkildsen O; Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital Bergen, Norway ; Kristian Gerhard Jebsen Centre for MS Research, Department of Clinical Medicine, University of Bergen Bergen, Norway., Aarseth J; Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital Bergen, Norway ; Kristian Gerhard Jebsen Centre for MS Research, Department of Clinical Medicine, University of Bergen Bergen, Norway., Celius EG; Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway., Holmøy T; Department of Neurology, Akershus University Hospital Lørenskog, Norway ; Institute of Clinical Medicine, University of Oslo Oslo, Norway., Kampman MT; Deptartment of Neurology, University Hospital of North Norway Tromsø, Norway., Løken-Amsrud KI; Institute of Clinical Medicine, University of Oslo Oslo, Norway ; Innlandet Hospital Trust Lillehammer, Norway., Midgard R; Department of Neurology, Molde Hospital Molde, Norway ; Unit for Applied Clinical Research, Norwegian University of Science and Technology Trondheim, Norway., Myhr KM; Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital Bergen, Norway ; Kristian Gerhard Jebsen Centre for MS Research, Department of Clinical Medicine, University of Bergen Bergen, Norway., Riise T; Department of Public Health and Primary Health Care, University of Bergen Bergen, Norway., Grytten N; Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital Bergen, Norway ; Kristian Gerhard Jebsen Centre for MS Research, Department of Clinical Medicine, University of Bergen Bergen, Norway.

Publikováno v: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2014 May; Vol. 1 (5), pp. 376-7. Date of Electronic Publication: 2014 Apr 10.